LOS ANGELES, April 19, 2018 -- With April being Alcohol Awareness Month, studies show 83% of people who drink excessively received no advice or encouragement from family and friends to cut down their drinking. Women with drinking problems were much less likely than men to receive advice with only 11.7% of them encouraged to seek help.
Using alcohol is socially acceptable and often even encouraged, despite the very real risks of substance abuse and health issues. According to a study published in JAMA Psychiatry, a staggering 1 in 8 Americans struggle with alcohol abuse.
“Hearing from friends or family that they might need help with alcohol is one of the main factors in people seeking treatment. And the sooner they get help, the sooner they can go on with their lives with a healthier relationship with alcohol,” says Dr. Diane Rothon, Medical Director for alcohol recovery program Alavida Health.
Only 10% of addicts ever get treatment
“The key to helping Americans with alcohol use disorder lies in having open and honest conversations about alcohol, helping people identify they have a problem, and finding them the right type of help to treat their addiction,” Dr. Rothon says.
Once someone has identified that they need help, finding the right kind of treatment is the next step. There are plenty of options, from traditional 12-step programs like AA to more revolutionary treatments such as Alavida Health, a science-based treatment program that promotes controlled drinking therapy instead of abstinence and touts a 75% success rate.
About Alavida
Alavida Health is a science-based treatment program that combines non-addictive medication, behavioral therapy and technology to help people decrease or stop their consumption of alcohol. Alavida clients work with their doctor and therapist for typically four to six months and can access their doctors in person or virtually, making the access barrier-free. Available in North America since 2016, Alavida currently has offices in Canada and the USA. The treatment model has a success rate of over 75 percent, in line with a clinical study and 20 years of ongoing practice conducted in Finland. More information about Alavida and how treatment works can be found at www.alavida.co.
Contact:
Binu Koshy
Media Relations
P: 905-617-1988 / 1-888-315-8550
E: [email protected]
Christine Gomes
Marketing Manager
E: [email protected]


Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny
Bathla Group Hires Administrators as Australia Housing Slump Deepens
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7%
Mercer International Stock Surges 45% on C$20 Million Canada Funding
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake
Trump Administration Plans New Drug Pricing Deals With Biotech Firms
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover
SEC Probes Banks Over Situational Awareness Hedge Fund Collapse
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
Trump Buys SpaceX Shares After Record IPO
Meta, U.S. States Discuss Settlement in Teen Addiction Trial 



